• 1.

    Aragon CLHofmeister EHBudsberg SC. Systematic review of clinical trials of treatments for osteoarthritis in dogs. J Am Vet Med Assoc 2007; 230: 514521.

    • Search Google Scholar
    • Export Citation
  • 2.

    Dassler CL. Canine hip dysplasia: diagnosis and nonsurgical treatment. In: Slatter D, ed. Textbook of small animal surgery. Philadelphia: Saunders, 2003; 20192027.

    • Search Google Scholar
    • Export Citation
  • 3.

    Farrell MClements DNMellor D, et al. Retrospective evaluation of the long-term outcome of non-surgical management of 74 dogs with clinical hip dysplasia. Vet Rec 2007; 160: 506511.

    • Search Google Scholar
    • Export Citation
  • 4.

    Schulz KSDejardin LM. Surgical treatment of canine hip dysplasia. In: Slatter D, ed. Textbook of small animal surgery. Philadelphia: Saunders, 2003; 20292059.

    • Search Google Scholar
    • Export Citation
  • 5.

    Montgomery RDMilton JLPernell R, et al. Total hip arthroplasty for treatment of canine hip dysplasia. Vet Clin North Am Small Anim Pract 1992; 22: 703719.

    • Search Google Scholar
    • Export Citation
  • 6.

    Olmstead ML. The canine cemented modular total hip prosthesis. J Am Anim Hosp Assoc 1995; 31: 109124.

  • 7.

    Olmstead MLHohn RBTurner TM. A five-year study of 221 total hip replacements in the dog. J Am Vet Med Assoc 1983; 183: 191194.

  • 8.

    Budsberg SCChambers JNVan Lue SL, et al. Prospective evaluation of ground reaction forces in dogs undergoing unilateral total hip replacement. Am J Vet Res 1996; 57: 17811785.

    • Search Google Scholar
    • Export Citation
  • 9.

    Skurla CTEgger ELSchwarz PD, et al. Owner assessment of the outcome of total hip arthroplasty in dogs. J Am Vet Med Assoc 2000; 217: 10101012.

    • Search Google Scholar
    • Export Citation
  • 10.

    US FDA. Approved animal drug products. Available at: www.fda.gov/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm056929.htm. Accessed Jan 8, 2010.

    • Search Google Scholar
    • Export Citation
  • 11.

    Dutka JDutka LJaniszewski M, et al. Cost analysis and socio-medical aspects of the conservative and surgical treatment of hip osteoarthritis. Orthop Traumatol Rehabil 2008; 10: 537546.

    • Search Google Scholar
    • Export Citation
  • 12.

    AVMA. Veterinary medical use and expenditures. In: US pet ownership & demographics sourcebook. Schaumburg, Ill: AVMA, 2007; 62.

  • 13.

    Escalante ABeardmore TD. Predicting length of stay after hip or knee replacement for rheumatoid arthritis. J Rheumatol 1997; 24: 146152.

    • Search Google Scholar
    • Export Citation
  • 14.

    Fortin PRClarke AELiang JL, et al. Outcomes of total hip and knee replacement: preoperative functional status predicts outcome at six months after surgery. Arthritis Rheum 1999; 42: 17221728.

    • Search Google Scholar
    • Export Citation
  • 15.

    Fortin PRPenrod JRClarke AE, et al. Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. Arthritis Rheum 2002; 46: 33273330.

    • Search Google Scholar
    • Export Citation
  • 16.

    Hajat SFitzpatrick RMorris R, et al. Does waiting for total hip replacement matter? Prospective cohort study. J Health Serv Res Policy 2002; 7: 1925.

    • Search Google Scholar
    • Export Citation
  • 17.

    Holtzman JSaleh KKane R. Effect of baseline functional status and pain on outcomes of total hip arthroplasty. J Bone Joint Surg Am 2002; 84: 19421948.

    • Search Google Scholar
    • Export Citation
  • 18.

    Lavernia CD'Apuzzo MRossi M, et al. Is postoperative function after hip or knee arthroplasty influenced by preoperative functional levels? J Arthroplasty 2009; 24: 10331043.

    • Search Google Scholar
    • Export Citation
  • 19.

    Nilsdotter AKLohmander LS. Age and waiting time as predictors of outcome after total hip replacement for osteoarthritis. Rheumatology 2002; 41: 12611267.

    • Search Google Scholar
    • Export Citation
  • 20.

    Andrews CMLiska WDRoberts DJ. Sciatic neurapraxia as a complication in 1000 consecutive canine total hip replacements. Vet Surg 2008; 37: 254262.

    • Search Google Scholar
    • Export Citation

Advertisement

Duration of clinical signs prior to total hip replacement in dogs

View More View Less
  • 1 Gulf Coast Veterinary Specialists, 1111 W Loop S Freeway, Ste 160, Houston, TX 77027.

Abstract

Objective—To compare the duration of clinical signs in dogs prior to total hip replacement (THR) for 2 time periods and to determine whether a previous THR influenced the duration of clinical signs prior to THR of the contralateral hip joint.

Design—Retrospective cohort study.

Animals—833 dogs that underwent unilateral THR (334 dogs between 1992 and 2000 [group 1] and 499 dogs between 2001 and 2009 [group 2]; part 1) and 272 dogs that underwent staged bilateral THR between 1992 and 2009 (part 2).

Procedures—Duration of pelvic limb lameness prior to THR was recorded in an in-house data registry. Mean duration of clinical signs was determined for both groups of dogs in part 1. For part 2, duration of clinical signs prior to the first THR was compared with the interval between surgeries in dogs that underwent bilateral THR.

Results—In part 1, duration of clinical signs was significantly longer for group 2 dogs than for group 1 dogs. In part 2, the duration of clinical signs prior to the first THR was significantly longer than the interval between surgeries.

Conclusions and Clinical Relevance—Between 1992 and 2009, the duration of clinical signs prior to THR in dogs increased significantly. In dogs that underwent bilateral THR, the interval between surgeries was shorter than the duration of clinical signs before the first THR. Developments in medical treatments of osteoarthritis, surgical preferences, and veterinarian recommendations may influence the interval between initial clinical signs and surgery.

Abstract

Objective—To compare the duration of clinical signs in dogs prior to total hip replacement (THR) for 2 time periods and to determine whether a previous THR influenced the duration of clinical signs prior to THR of the contralateral hip joint.

Design—Retrospective cohort study.

Animals—833 dogs that underwent unilateral THR (334 dogs between 1992 and 2000 [group 1] and 499 dogs between 2001 and 2009 [group 2]; part 1) and 272 dogs that underwent staged bilateral THR between 1992 and 2009 (part 2).

Procedures—Duration of pelvic limb lameness prior to THR was recorded in an in-house data registry. Mean duration of clinical signs was determined for both groups of dogs in part 1. For part 2, duration of clinical signs prior to the first THR was compared with the interval between surgeries in dogs that underwent bilateral THR.

Results—In part 1, duration of clinical signs was significantly longer for group 2 dogs than for group 1 dogs. In part 2, the duration of clinical signs prior to the first THR was significantly longer than the interval between surgeries.

Conclusions and Clinical Relevance—Between 1992 and 2009, the duration of clinical signs prior to THR in dogs increased significantly. In dogs that underwent bilateral THR, the interval between surgeries was shorter than the duration of clinical signs before the first THR. Developments in medical treatments of osteoarthritis, surgical preferences, and veterinarian recommendations may influence the interval between initial clinical signs and surgery.

Contributor Notes

Dr. Lockwood's present address is the Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, 1008 W Hazelwood Dr, Urbana, IL 61802.

Address correspondence to Dr. Lockwood (lockwood@illinois.edu).